Know What's Happening in Healthcare
Know What's Happening in Healthcare
FDA approves KRESLADI, first CIRM‑backed gene‑editing therapy
The FDA cleared KRESLADI, a gene‑editing treatment from Rocket Pharmaceuticals for severe leukocyte adhesion deficiency‑I in children, eliminating the need for a bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine to receive approval.
Also developing:
By the numbers: Syneron Bio raises $150M Series B
Meiji Seika Pharma announced a strategic investment in U.S. biotech Centivax to accelerate its universal influenza vaccine, Centi‑Flu 01, currently in Phase 1 trials. The partnership leverages Meiji’s pharmaceutical expertise and Centivax’s computational immune‑engineering platform to target conserved viral regions, aiming for broad, durable protection against seasonal and pandemic flu. Meiji’s funding also supports Centivax’s expanding pipeline, which includes candidates for Alzheimer’s, oncology, malaria and a universal antivenom. The deal underscores a growing focus on next‑generation, cross‑border vaccine collaborations.
An Australian scientific review concluded that vaping likely increases the risk of lung and oral cancer, marking the most definitive link to date. The analysis relied on short‑term laboratory and human exposure studies because long‑term cohort data are unavailable. While...
Travel nurses can command top-tier pay by targeting high‑acuity settings such as trauma centers, intensive care units, operating rooms, and specialized labor‑delivery or NICU units. Specialized certifications like CCRN, TNCC, and RNC‑OB dramatically increase bargaining power, while geographic flexibility lets...
Spotify co‑founder Daniel Ek has launched Neko Health, a full‑body scanning startup, with its first U.S. clinic slated for New York. The service combines advanced imaging of vascular, organ and metabolic systems to flag serious conditions, reporting 1.2% of scans...
Advanced eClinical Training (ACT) has partnered with Emory University’s HeartStart program to launch a customized Clinical Medical Assistant (CCMA) training pathway for pre‑medical students. The inaugural cohort will include 50 learners who will receive certification preparation, simulation‑based patient‑care training, and...
The FDA approved a high‑dose formulation of Biogen’s SMA drug Spinraza, cutting the loading phase from four to two injections and adding a four‑month maintenance schedule. The new regimen, backed by the DEVOTE study, showed significant motor‑skill gains versus sham...
Artificial intelligence is sparking an adversarial arms race in healthcare utilization management, pitting provider‑centric approval bots against payer‑focused denial algorithms. The clash threatens patient access, inflates provider burnout, and undermines trust. Simultaneously, regulators are pushing for real‑time, FHIR‑based authorizations under...
AstraZeneca is testing its COPD triple‑inhaler Breztri Aerosphere in uncontrolled asthma. Phase III KALOS and LOGOS trials showed 76‑90 mL improvements in FEV₁ and a 14% reduction in severe exacerbations versus standard ICS/LABA therapy. The studies enrolled about 4,300 patients across 20...
Red and near‑infrared light therapy, known as photobiomodulation, has shifted from clinics to the consumer health market, prompting a surge in device sales and investor interest. In the United States, products reach consumers via distinct FDA pathways: 510(k) clearance for...
An international team of more than 40 scientists released the human E3‑ome, a curated atlas that consolidates 672 high‑confidence E3 ligases from over 1,100 candidates. The resource offers a gold‑standard reference for basic research and drug discovery, addressing long‑standing inconsistencies...
The U.S. Department of Agriculture rolled out a redesigned food pyramid that pivots toward whole, minimally processed foods and away from refined, ultraprocessed staples. The shift arrives as more than 70% of American adults are overweight or obese and one‑in‑three...
Researchers at Sweden's Karolinska Institute reported that an hour of mentally active sitting—such as knitting, puzzles or office work—lowers dementia risk by up to 7% compared with passive screen time. The 20‑year longitudinal study of 20,811 adults links cognitive engagement...
Hybrid hub models are evolving from basic administrative functions into coordinated ecosystems that link manufacturers, distributors, specialty pharmacies, and service providers. This shift transforms vendor relationships into strategic partnerships involving dozens of stakeholders. Automation and digital intake are compressing prior‑authorization...
The requested story about Novartis acquiring Excellergy for up to $2 billion cannot be produced because none of the provided source material contains any details about this transaction.
Scientists at Manchester University have identified a recessive RNU2‑2‑related neurodevelopmental disorder as one of the most common genetic causes of childhood epilepsy. The condition, which manifests with seizures and severe delays in speech and walking before age one, has been...
A recent poll shows one in five Australians regret postponing private health insurance, citing cost‑saving shortcuts that could trigger a surge in future enrollment. The finding comes as households grapple with higher fuel, food and housing expenses, prompting insurers to...
The New England Journal of Medicine released the CREST‑2 results, a pair of parallel randomized trials that compared intensive medical management (IMM) alone with IMM plus either carotid stenting (TFCAS) or carotid endarterectomy (CEA) in patients with asymptomatic high‑grade carotid...
Berkshire Hathaway’s newly disclosed 5.04 million‑share position in UnitedHealth Group, valued at $1.57 billion in August 2025, has been hit by a 17% slide in the insurer’s stock, creating an unrealized loss of roughly $267 million. The loss highlights the pressure on UnitedHealth’s...
A large Kaiser Permanente cohort study found that women with gestational diabetes who achieve stable, optimal glucose levels have offspring obesity risk similar to those without gestational diabetes. Women whose glucose control improves slowly or remains suboptimal face 1.3‑to‑1.6 times...
The module introduces HitID screens, outlining key strategies for early-stage drug discovery. It references recent literature on medicinal chemistry optimization, successful hit‑to‑clinical transitions, DNA‑encoded library (DEL) approaches, ultra‑low‑molecular‑weight crystallographic screening, and fragment‑based drug discovery (FBDD). By consolidating these sources, the...
Zongertinib (Hernexeos) received FDA accelerated approval for first‑line treatment of HER2‑mutant advanced NSCLC, based on Beamion LUNG‑1 data presented at the European Lung Cancer Congress. In previously untreated patients (cohort 2), the drug achieved a 76% objective response rate and a...
Dental practices are losing roughly 15% of their patient base each year, yet 68% still rely only on word‑of‑mouth referrals. The American Dental Association reports that offices that adopt comprehensive, digital‑first attraction strategies achieve 32% higher annual growth. Patients now...
A recent case report documents a healthy 30‑year‑old male who developed myocarditis three days after his second Pfizer mRNA COVID‑19 shot. Cardiac magnetic resonance (CMR) imaging performed eight weeks later revealed mid‑to‑epicardial lateral wall fibrosis, which persisted, though partially resolved,...
Middleton, Wisconsin, announced that veteran paramedic Kris O’Dell has been named chief of its Emergency Medical Services Department. The appointment, approved by the Middleton Common Council in February, follows O’Dell’s nearly 32 years in EMS, including over 25 years as...
On World Bipolar Day, Mind Cymru called on the incoming Welsh Government to invest in anti‑stigma programmes after its Big Mental Health Report showed a decline in workplace willingness to work with people with mental health problems. A 2025 YouGov...
1/🚨@TesseraTx has announced that it has received a grant from the Gates Foundation to fund an early-stage research which is aimed to develop a Gene Editing-based cure for HIV. This grant is build upon Tessera’s existing investment 🧵👇 from the Gates...
“Longevity tourism” Plenty of folks willing to travel & pay for “stem cells as magical thinking” and a growing panoply of unproven & sometimes dangerous “#longevity” therapies. Caveat emptor. By @PeterWardJourno in @Slate https://t.co/jq9rPrcRK2
The United States’ de‑facto oil blockade has triggered prolonged electricity blackouts across Cuba, crippling hospitals and forcing the Center of Molecular Immunology (CIM) to suspend eight of its ten active clinical trials. Supply shortages and a collapsed transport network are...
MAID supporters are some of the most weaselly people I've encountered on this website https://t.co/YsZoSvPGZU
Dr. Mark Sircus promotes a "Natural Allopathic Medicine" model that prioritizes essential nutrients and gases—oxygen, water, magnesium, carbon dioxide, iodine, selenium, vitamins C and D, bicarbonate, hydrogen, PPC, and chlorine dioxide—over conventional pharmaceuticals. He argues that high‑dose administration of these...
Tennessee Senate Bill 1947 aimed to guarantee patients the right to receive autologous or directed blood transfusions ordered by their physicians. The measure cleared the Senate Health Committee and passed the Senate floor 25‑6, but stalled in a later committee...
UK Biotech Day 2026 will take place on May 27‑28 at the Radisson Hotel & Conference Centre London Heathrow. The two‑day conference convenes executives, R&D scientists, investors, legal and finance professionals from pharma, biotech, medtech, and tech‑bio sectors. Positioned as...
LiftWell Health merged Lift Wellness Group and LiftWell under a single brand, unveiling a new website to present a unified clinical vision across Connecticut and the broader Northeast. The organization appointed Awstin Gregg, MBA, LCSW‑S, LCDC, as President and Board...
Edith H. Quimby, a pioneering physicist, established the field of radiation dosimetry in the mid‑20th century. Her methods allowed precise measurement of radiation absorbed by the human body, transforming medical imaging and radiation therapy from guesswork to quantifiable science. The...
The Centers for Medicare & Medicaid Services (CMS) will launch the Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) model on July 5, 2026, a ten‑year voluntary payment experiment for fee‑for‑service Medicare beneficiaries with hypertension, diabetes, chronic musculoskeletal pain or depression. The...
The Resources for Every School Confronting Unexpected Emergencies Illinois (RESCUE‑IL) stock inhaler program was evaluated across 483 Illinois public schools, with 327 nurses and staff responding. Satisfaction was high, with 96.3% reporting they were very satisfied or satisfied, and 95.9%...
The National Partnership for Healthcare & Hospice Innovation (NPHI) has urged the Centers for Medicare & Medicaid Services (CMS) to impose a temporary, nationwide moratorium on new hospice provider enrollments, citing a rise in fraudulent operators. The organization’s letter also...
The U.S. FDA has approved a higher‑dose version of Biogen’s gene‑replacement therapy for a rare genetic muscle‑weakening disorder, likely spinal muscular atrophy. The new regimen starts with two 50 mg loading doses two weeks apart, followed by a 28 mg maintenance dose...
Tufts University researchers found that U.S. life expectancy improvements have stalled over the last decade, with baby‑boomers (born 1950‑59) and the 1970‑85 cohort experiencing lower longevity than their predecessors. The study links the slowdown primarily to rising mortality from cardiovascular...
Morning Light Inc., an Indiana nonprofit, is tackling the hospice gap for aging homeless individuals by providing free housing alongside end‑of‑life care. In 2023 the organization cared for 51 hospice patients, averaging 58 days per stay, within its 12‑room facility....
Dr. Robert Malone resigned from the CDC’s vaccine advisory committee, alleging the agency is plagued by internal sabotage and constant bickering. He claims a "mole"—appointed by Robert F. Kennedy Jr.—is embedded within the CDC to undermine vaccine policy. Malone speculates...
Katie Schenk, a veteran public‑health epidemiologist, publicly disclosed that she recently resigned from the CDC after years of keeping her federal role hidden. She explains that growing political pressure and a widening gap between scientific evidence and agency decisions made...
CVS Health announced the launch of its first pharmacy‑only store in Chicago and plans to open nearly 20 similar locations by year‑end. The new format, about 3,000 square feet, focuses on prescription fulfillment, vaccinations and a curated OTC assortment, cutting...
India's Union Ministry of Ayush has launched a nationwide, evidence‑based Yoga Protocol for Non‑Communicable Diseases, targeting diabetes, hypertension, asthma and mental health. The initiative, unveiled at Yoga Mahotsav 2026, seeks to shift the health system from treatment to prevention.
Researchers from the Chinese Academy of Sciences have built a fully superconducting user magnet that reached 35.6 tesla, shattering the previous 32.0‑tesla record. The breakthrough, demonstrated on Jan. 23, 2026, promises unprecedented magnetic‑field capability for high‑field science, nuclear‑fusion experiments and next‑generation...
A comprehensive 2026 meta‑analysis of 113 clinical trials and nearly 8,000 participants concludes that hydrolysed collagen supplements produce moderate improvements in muscle health, lessen osteoarthritis pain, and enhance skin elasticity and hydration. The findings revive scientific and consumer interest in...
Researchers analyzing more than 15,000 human fat samples have identified the SLIT3 protein as a potent enhancer of brown‑fat calorie burning. The discovery suggests a novel, metabolism‑focused avenue for obesity treatment and biohacking beyond appetite‑suppressing drugs.
A Chinese biotech company administered the first-in-human dose of a hepatitis D‑targeted monoclonal antibody in Beijing, marking a world‑first for the disease. The trial details were not disclosed, and it comes as the broader pharma sector grapples with earnings pressure,...
